Hypophosphatemic rickets

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:437
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hypophosphatemic rickets is a group of rare genetic disorders characterized by renal phosphate wasting, leading to chronically low levels of phosphate in the blood (hypophosphatemia) and defective mineralization of bones and teeth. The most common form is X-linked hypophosphatemic rickets (XLH), caused by mutations in the PHEX gene, but autosomal dominant and autosomal recessive forms also exist (caused by mutations in FGF23, DMP1, ENPP1, CLCN5, and other genes). The condition is also known as vitamin D-resistant rickets because it does not respond to standard vitamin D supplementation. The disease primarily affects the skeletal system, leading to bowing of the legs, short stature, bone pain, and fractures. In children, the hallmark features include progressive leg bowing (genu varum or genu valgum), widening of the wrists and knees, delayed walking, waddling gait, and impaired growth. Dental manifestations are common and include spontaneous dental abscesses, enamel defects, and enlarged pulp chambers. Adults may experience osteomalacia, enthesopathies (calcification of tendons and ligaments), joint stiffness, pseudofractures, hearing loss, and chronic musculoskeletal pain. The kidneys are functionally involved as the primary site of phosphate loss, though kidney function is otherwise typically preserved. Traditional treatment has consisted of oral phosphate supplementation combined with active vitamin D analogs (calcitriol or alfacalcidol) to improve phosphate balance and promote bone mineralization. However, this regimen requires careful monitoring due to risks of nephrocalcinosis and secondary hyperparathyroidism. A major therapeutic advance came with the approval of burosumab (Crysvita), a monoclonal antibody targeting FGF23, which has been shown to significantly improve phosphate levels, rickets severity, growth, and pain in both children and adults with XLH. Orthopedic surgery may be needed for severe skeletal deformities that persist despite medical treatment.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hypophosphatemic rickets.

View clinical trials →

No actively recruiting trials found for Hypophosphatemic rickets at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hypophosphatemic rickets community →

No specialists are currently listed for Hypophosphatemic rickets.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hypophosphatemic rickets.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hypophosphatemic ricketsForum →

No community posts yet. Be the first to share your experience with Hypophosphatemic rickets.

Start the conversation →

Latest news about Hypophosphatemic rickets

No recent news articles for Hypophosphatemic rickets.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hypophosphatemic rickets

What is Hypophosphatemic rickets?

Hypophosphatemic rickets is a group of rare genetic disorders characterized by renal phosphate wasting, leading to chronically low levels of phosphate in the blood (hypophosphatemia) and defective mineralization of bones and teeth. The most common form is X-linked hypophosphatemic rickets (XLH), caused by mutations in the PHEX gene, but autosomal dominant and autosomal recessive forms also exist (caused by mutations in FGF23, DMP1, ENPP1, CLCN5, and other genes). The condition is also known as vitamin D-resistant rickets because it does not respond to standard vitamin D supplementation. The d

At what age does Hypophosphatemic rickets typically begin?

Typical onset of Hypophosphatemic rickets is childhood. Age of onset can vary across affected individuals.